For the year ending 2025-12-31, CFLT had -$38,770K decrease in cash & cash equivalents over the period. $60,677K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net loss | -295,275 | -345,065 | -442,746 | -452,551 |
| Depreciation and amortization | 29,556 | 22,089 | 13,910 | 7,620 |
| Net accretion of discounts on marketable securities | 22,300 | 37,766 | 42,505 | 8,891 |
| Amortization of debt issuance costs | 3,839 | 3,836 | 3,813 | 3,799 |
| Amortization of deferred contract acquisition costs | 58,310 | 54,258 | 45,888 | 37,339 |
| Non-cash operating lease costs | 4,300 | 3,966 | 3,992 | 8,608 |
| Lease abandonment charges | 0 | 0 | 15,667 | - |
| Common stock charitable donation expense | - | - | 0 | 0 |
| Stock-based compensation, net of amounts capitalized | 397,325 | 395,660 | 349,833 | 277,656 |
| Deferred income taxes | -18,699 | 277 | 1,889 | -237 |
| Other | -5,686 | -3,370 | -2,358 | -1,384 |
| Accounts receivable | 79,718 | 86,562 | 53,593 | 42,080 |
| Deferred contract acquisition costs | 71,853 | 53,246 | 61,354 | 62,801 |
| Prepaid expenses and other assets | 25,394 | -844 | 10,387 | 17,850 |
| Accounts payable | 13,466 | 127 | -14,452 | 13,580 |
| Accrued expenses and other liabilities | -15,512 | 25,639 | 61,333 | 9,948 |
| Operating lease liabilities | -8,894 | -10,140 | -7,479 | -9,209 |
| Deferred revenue | 89,437 | 56,173 | 30,176 | 76,352 |
| Net cash provided by (used in) operating activities | 64,274 | 33,460 | -103,657 | -157,333 |
| Capitalization of internal-use software costs | 22,558 | 21,404 | 17,845 | 10,334 |
| Purchases of marketable securities | 1,638,898 | 1,539,716 | 1,586,693 | 2,051,908 |
| Sales of marketable securities | 6,144 | 15,311 | - | 0 |
| Maturities of marketable securities | 1,474,654 | 1,591,164 | 1,578,323 | 1,200,558 |
| Purchases of investments in privately-held companies | 750 | 2,250 | - | - |
| Purchases of property and equipment | 3,597 | 2,567 | 2,834 | 4,121 |
| Cash paid for business combinations, net of cash acquired | 0 | 115,516 | 55,802 | - |
| Other | - | - | 0 | 0 |
| Net cash used in investing activities | -185,005 | -74,978 | -84,851 | -865,805 |
| Proceeds from initial public offering, net of underwriting discounts and commissions | - | - | 0 | 0 |
| Proceeds from issuance of common stock upon exercise of vested options | 57,260 | 55,836 | 73,919 | 42,461 |
| Proceeds from issuance of common stock upon early exercise of unvested options | - | 0 | 0 | 416 |
| Repurchases of unvested common stock | 0 | 0 | - | 789 |
| Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | - | - | - | 0 |
| Repurchases of unvested common stock | - | - | 255 | - |
| Payments of deferred offering costs | - | - | 0 | 0 |
| Proceeds from convertible senior notes, net of issuance costs | - | - | 0 | -786 |
| Payments for purchase of capped calls | - | - | 0 | 0 |
| Payments of debt issuance costs for convertible senior notes | - | 0 | - | - |
| Proceeds from issuance of common stock under employee stock purchase plan | 23,926 | 23,970 | 28,708 | 40,939 |
| Net cash provided by financing activities | 81,186 | 79,806 | 102,372 | 82,241 |
| Effect of exchange rate changes on cash and cash equivalents | 775 | -2,069 | 116 | -4 |
| Net (decrease) increase in cash and cash equivalents | -38,770 | 36,219 | -86,020 | -940,901 |
| Cash and cash equivalents at beginning of period | 385,980 | 349,761 | 435,781 | 1,376,682 |
| Cash and cash equivalents at end of period | 347,210 | 385,980 | 349,761 | 435,781 |
Confluent, Inc. (CFLT)
Confluent, Inc. (CFLT)